Results 271 to 280 of about 5,310,608 (313)
Some of the next articles are maybe not open access.
Radiologic Clinics of North America, 2008
This article outlines the changes seen using various imaging modalities in the normally aging brain and then discusses in detail the changes seen with various pathologic conditions. Entities discussed include primary degenerative dementias, extrapyramidal system diseases, and vascular dementias.
Gallucci M. +3 more
openaire +3 more sources
This article outlines the changes seen using various imaging modalities in the normally aging brain and then discusses in detail the changes seen with various pathologic conditions. Entities discussed include primary degenerative dementias, extrapyramidal system diseases, and vascular dementias.
Gallucci M. +3 more
openaire +3 more sources
RBD and Neurodegenerative Diseases
Molecular Neurobiology, 2016Rapid eye movement (REM) sleep behavior disorder (RBD) is a sleep disorder characterized by enacting one's dreams during the REM sleep, with most of the dreams being violent or aggressive, so that patients often come to see the doctor complaining hurting themselves or bed partners during sleep.
Haiyang, Jiang +12 more
openaire +2 more sources
Prions and Neurodegenerative Diseases
New England Journal of Medicine, 1987CREUTZFELDT–JAKOB disease (CJD), kuru, and the Gerstmann–Straussler syndrome are human neurodegenerative diseases that can be transmitted experimentally to animals.
Franklin H. Epstein, Stanley B. Prusiner
openaire +2 more sources
Gangliosides in Neurodegenerative Diseases
2022The main purpose of this chapter is to summarize the chief findings on ganglioside changes/interactions with some of the neurodegenerative disorders. For the latter we have focused on three diseases that have seen especially intensive study in that regard: Parkinson's, Alzheimer's, and Huntington's diseases.
Robert, Ledeen, Suman, Chowdhury
openaire +2 more sources
Neuroprotection and Neurodegenerative Disease
Journal of Clinical Neuroscience, 2002This paper will focus on commonalities in the aetiology and pathology in five areas of neurological disease with illustrative examples of therapy. Possibilities of multimodal and neuroprotective therapies in human disease, employing currently available drugs and showing evidence of neuroprotective potential in animal models, are discussed.
openaire +2 more sources
Neurodegenerative Diseases and Ageing
2019This chapter describes the main neuropathological features of the most common age associated neurodegenerative diseases including Alzheimer's disease, Lewy body diseases, vascular dementia and the various types of frontotemporal lobar degeneration.
Walker L +3 more
openaire +3 more sources
Glycosaminoglycans in Neurodegenerative Diseases
2021Glycosaminoglycans (GAGs) are linear polysaccharides that consist of alternating disaccharides sequences of uronic acids and/or galactose hexamino sugars most of which are sulfated. GAGs are ubiquitously expressed on the cell surface, in the intracellular milieu and in the extracellular matrix of all animal cells.
Weihua, Jin +2 more
openaire +2 more sources
Sleep in Neurodegenerative Diseases
Sleep Medicine Clinics, 2016Disorders of sleep are an integral part of neurodegenerative diseases and include insomnia, sleep-wake cycle disruption, excessive daytime sleepiness that may be manifested as persistent somnolence or sudden onset of sleep episodes, obstructive and central sleep apnea, rapid eye movement sleep behavior disorder, and restless legs syndrome.
openaire +2 more sources
Apoptosis in Neurodegenerative Diseases
1997Publisher Summary This chapter reviews pathological features of various neurodegenerative diseases, the relevance of apoptosis in their pathogenesis, and underlying genetic abnormalities. The chapter also describes proposed mechanisms for Alzheimer's disease (AD) neurodegeneration.
I, Nishimoto +3 more
openaire +2 more sources
Meditation and neurodegenerative diseases
Annals of the New York Academy of Sciences, 2013Neurodegenerative diseases pose a significant problem for the healthcare system, doctors, and patients. With an aging population, more and more individuals are developing neurodegenerative diseases and there are few treatment options at the present time.
Andrew B, Newberg +5 more
openaire +2 more sources